chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started with some erythema and tenderness around injection site of Pneumovax23. By 24 hours after injection had temp of 102° and the redness extended in a 6" diameter around injection site.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin; "Known allergies: Sulfa" (unspecified if ongoing), notes: Known allergies: Penicillin Sulfa. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid start on 07Jun2022 till 11Jun2022.  Clinical course: The patient did not receive any other medications in 2 weeks. It was reported that on 20Jun2022 reoccurrence of symptoms 10 days post Paxlovid treatment end date and patient was recovering.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The reported Covid 19 positive after both the doses of  COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
Information has been received from a licensed practical nurse (LPN) concerning a patient who was vaccinated with a dose of varicella virus vaccine live. The LPN reported that, in approximately September 2003, the patient in developed chickenpox. The LPN also reported that the patient exposed a cousin to chickenpox (WAES #0310USA01481). Additional information has been requested.
he felt dizzy; This is a spontaneous report from a contactable consumer (patient himself). A 70-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, after first COVID-19 Vaccine, he felt dizzy on an unspecified date. The outcome of the event was unknown.   Information about batch/lot number has been requested.
Nosebleeds began on June 27, 2021 after never having had nosebleeds before.  They came intermittently, sometimes, days apart, and sometimes a week or so apart.   I went to Urgent Care once who referred me to ENT Dr. who did eval.  Thought deviated septum might play a part. Prescribed Afrin for 3 days.  Nosebleeds stopped for about 1-1/2 weeks and then began again.  CT scan of sinuses was ordered with negative findings.  Went to ED during one night when nosebleed wouldn't stop - bp was 148/80.  Was again given a form of Afrin .  Dr. recom I see PCP to evaluate need for BP meds.  Nosebleeds stopped beginning of Oct. 2021.  I began Losartan 25 on 10/28/21.
COVID 19 breakthrough infection; COVID 19 breakthrough infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old male patient received BNT162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Lot number: EN6203), on 23Mar2021 as dose 2, single (Lot number: EN6203) and on 25Oct2021 as dose 3 (booster), single (Lot number: FH8020) at the age of 49 years, all intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Sleep Apnea" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing); "Acid Reflux" (unspecified if ongoing). Concomitant medication(s) included: LEXAPRO; PRAVASTATIN; FAMOTIDINE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 14Jul2022 at 18:00, outcome "recovering" and all described as "COVID 19 breakthrough infection". The event "covid 19 breakthrough infection" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Jul2022) Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: It was reported that, the patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. No known allergies. The patient also received other medication in two weeks which were reported as multivitamin and CPAP.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
That was my second shot of COVID vaccination.  My left arm felt pain one next day after the vaccination, one week later, my both ears started tinnitus really bad.  There are all kinds of sharp noises ringing in my ears every second all times.  My head looks like is going to explode .  I had my doctors looked at it.  Not helping,
Information has been received from a physician concerning a 75 year old white female with sulfonamide allergy, allergic reaction to antibiotics, vitamin b12 deficiency, hypertension, gastrooesophageal reflux disease, osteoporosis and asthma and a history of chickenpox, irritable bowel syndrome and depression history of chickenpox who on 27-SEP-2007 at 9:30 AM was vaccinated SC on left upper extremity with a first 0.5 ml dose of zoster vaccine live (Oka/Merck) (Lot # 658081/0743U). Concomitant therapy included aspirin, cyanocobalamin, lubiprostone (AMITIZA), gabapentin, verapamil, HCTZ/triamterene (MAXZIDE), paroxetine HCl (PAXIL), loratadine (CLARITIN), clonazepam (KLONOPIN), acetaminophen (+) tramadol hydrochloride (ULTRACET) and levothyroxine Na (LEVOXYL). Concomitant therapy on 12-OCT-2007 included a IM dose on right upper extremity of influenza virus split viron 3v vaccine inactivated (FLUZONE) (Lot # U2448ABB). There was no illness at the time of vaccination. On 29-SEP-2007 (previously reported 01-OCT-2007) the patient experienced headache, general malaise, and developed small, red "shingles like" bumps at injection site. Unspecified medical attention was sought. No diagnostic laboratory tests were undertaken. At the time of the report the patient was recovering. A product quality complaint was not involved. Additional information has been received from a physician who stated that on 29-SEP-2007 had red arm with central smaller area of vesicular lesions at the injection site. The patient was afebrile and rated the pain as 3 on the 0 to 10 scale where in 10 being the highest. Other systemic symptoms included itching, malaise, fatigue and headache. The patient had no recent exposure to chickenpox  or herpes zoster. The patient had multiple vesicular rashes in one area on the left upper arm only. At the time of the report the patient had recovered. Additional information has been received from the registered nurse who stated that the patient experienced headache, developed a large hot itchy vesicular and macular rash. The patient also experienced malaise, fatigue and tongue discomfort. On approximately 7-OCT-2007 the patient recovered. There was no adverse event following prior vaccination for the patient and patient's sibling. No further information is expected.
Extremely tired slept 12 hours straight; Extremely tired slept 12 hours straight; very sore arm; weakness; muscle aches; This is a spontaneous report from a contactable consumer (patient). A 67-years-old non pregnant female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6206), dose 1 via an unspecified route of administration, administered in Arm Right on 08Mar2021 10:00 as single dose for covid-19 immunization at Pharmacy or Drug Store. Medical history included known allergies which is not specified. Concomitant medications included metoprolol (METOPROLOL) 50 MG twice a day and amlodipine besylate (AMLODIPINE BESYLATE). Patient did not have covid prior vaccination. Patient was not covid tested post vaccination. Patient did not have other vaccine in four weeks. On 08Mar2021 15:00, the patient experienced Extremely tired slept12 hours straight, very sore arm, weakness, and muscle aches. Treatment was not received for adverse events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Received Pfizer Covid vaccine on January 13, 2021.  I noticed a rash across shoulders and back on 1/15/21.
This initial spontaneous case, was received on 07-Nov-2017, from a consumer, concerning a 05-year-old female child. On 06-Nov-2017, at 17:00 hrs (05:00 pm), the patient was administered with FLUCELVAX QIV (dose: 0.5ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 195240A and expiry date: unspecified date in Jun 2018). On the same day of vaccination, the patient vomited profusely overnight. On 07-Nov-2017, patient had completely recovered from the event. The reporter assessed this case as non-serious. The causality was assessed as related between the vaccine and event. Follow up report received on 11-Dec-2017: Batch number and expiry date was added. The narrative was amended accordingly.
severe pain in all joints normally affected by her arthritis.; This spontaneous report was received from a female nurse practitioner of unknown age via Pfizer regarding herself. The patient's concurrent conditions included rheumatoid arthritis.  The patient's medical history was not reported. The patient's historical therapy included vaccination with pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (PREVENAR 13).  On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), (dose, route, anatomical location, lot number and expiration date were not reported) for prophylaxis.  On an unknown date after 8 weeks of vaccination with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), the patient experienced severe pain in all joints normally affected by her arthritis (arthralgia). The patient stated that she experienced the same symptoms when she was vaccinate with pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (PREVENAR 13) which were resolved after 30 hours.  At the time of the report, the outcome of the arthralgia was unknown.   The relatedness between the event of arthralgia and therapy with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was not reported.
RECEIVED ONE DOSE J & J VACCINE ON NOV 1, 2021 MATTER OF 3-4 HOURS AFTER VACCINE DEVELOPED GENERALIZED JOINT PAIN - SO SEVERE NOTHING RELIEVED IT - NO MED, NO POSITION ETC. - SLIGHT NAUSEA SUBSIDED QUICKLY, GENERALIZED WEAKNESS, LETHARGY, UNSTEAD GAIT, LOSS OF APPETITE, SIGNIFICANT WT LOSS THIS LED TO 3-4 FALLS DURING THIS PERIOD OF 3 - 3 1/2 MONTHS IN WHICH I FURTHER DEVELOPED (L) SIDED ABDOMINAL PAIN WHICH PERSISTED ANTACIDS ETC NO EFFECT - NO CHANGE WITH ANTIBODIES ETC. - THIS CONTINUED SEVERAL DAYS BEFORE SUBSIDING AS TIME WENT ON - BILATERAL LOWER EXTREMITY MUSCLE CRAMPS (EVEN IN ANKLES) DEVELOPED PHLEBITIS/CELLULITIS IN ONE LOWER EXTREMITY WITH BILATERAL ANKLE EDEMA RX FOR KEFLEX PRESCRIBED BY MY PRIMAR MD VIA VERBAL CONTACT - UNABLE TO GO TO OFFICE IN MY CONDITION - THIS RESOLVED AFTER TREATMENT - STILL HAD "VEIN SORENESS" BOTH LOWER EXTREM JOINT / MUSCULAR PAIN SUBSIDED AFTER SEVERAL DAYS WITH EXCEPTION OF SCIATI (L) AND CERVICAL PAIN IN ADDITION (L) EAR / JAW AREA DISCOMFOR LASTED SEVERAL DAYS  LATER IN THIS PERIOD DEVELOPED PELVIC PAIN - 72 YRS OLD SYMPTOMS REMINDED ME OF PRE-MENSTRUAL SYMPTOMS YEARS AGO HEADACHE, LOWER BACK PAIN SUBSIDED WITHIN A FEW DAYS HAD EPISODES OF AMNESIA (LOSS/MEMORY) COLOR VISION CHANGES - MULTIPLE DAYS OF NAPPING FREQUENTLY PLEASE NOTE NO FEVER, NO LOSS OF SMELL ETC. 11/29/21 TAKEN TO HOSPITAL - MD NEVER EXAMINED ME THIS WAS TOLD TO MEDICAL DIRECTOR OF ER - ORDERED BLOOD WORK ONLY NEVER EXPLAINED TO ME - AS A NURSE READ HOSPITAL PAPERS (DX AS ACUTE RENAL FAILURE, DEHYDRATION) ONLY TX GIVEN WAS 1 LITTER OF NORMAL SALINE AFTER HOURS OF WAITING FOR ATTENTION 21 DAYS AFTER VACCINE ADMINISTRATION ABLE TO SLEEP WITHOUT AWAKENING WITH EARLIER DESCRIBED JOINT/MUSCULAR PAIN 2 WKS AFTER VACCINE DEVELOPED SORENESS AT INJECTION SITE - NONE PREVIOUSLY SUBSIDED QUICKLY DEVELOPED BILATERAL HAND TREMORS NOT SURE OF DURATION OBTAINED MEDICAL RECORDS WHICH DIDN'T REVEAL TRUTH RE: MY LACK OF CARE RE: PHYSICAL EXA PLEASE NOTE SAME BLOOD TESTS WERE NORMAL (APROX) 1 MONTH PRIOR TO LABS DRAWN AT HOSPITAL HOSPITAL LABS INDICATED INCREASED LIVER ENZYMES LOW PLATELET COUNT, LOW PROTEIN, ELECTROLYTE IMBALANCE, LOW BLOOD COUNT (ANEMIA) INCREASED BUN / KIDNEY FUNCTION TESTS GROSSLY ABNORMAL FORGOT TO MENTION EPISODES OF COUGHING PERSIST PRODUCTIVE AND NON-PRODUCTIVE - NEEDED NEBULIZER TX INHALERS ETC. - COUGH LESSENED TIME BUT HAD FOR GOOD 3 MONTHS ALSO (L) THIGH PAIN NOTICED NO GROWTH OF HAIR SINCE ONSET OF THIS - VERIFIED BY BEAUTY INSTRURCTOR - NO GROWTH OF HAIR ON LOWER EXTREIMITES ALSO - SAID MY HAIR WASN'T AS FULL AS USUAL - THIS IS ONLY THING THAT HAS REMAINED 3 - 4 MONTHS AFTER INCIDENT ALL LABS BACK TO NORMAL PLEASE NOTE UNFORTUNATELY MD LISTED ON ER RECORD NEVER EXAMINED ME - JUST ORDERED LABS - TOO SICK TO VISIT MY PRIMARY PHYSICIAN SAW ME AFTER SYMPTOMS SUBSIDED
Body aches; Fever; Fatigue; Joint pain; Rash on right hand (injection in left arm); Immediate pain at injection site, lasting 4 days; Feeling brain fog; Asthma; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Oct2021 (Lot number: FE3590) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Covid long-hauler, having been diagnosed in Mar202. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization; Bnt162b2 (Dose: 2), for COVID-19 Immunization. The following information was reported: INJECTION SITE PAIN (non-serious) with onset 13Oct2021, outcome "recovered" (Oct2021), described as "Immediate pain at injection site, lasting 4 days"; PAIN (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Body aches"; PYREXIA (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Fever"; FATIGUE (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Fatigue"; ARTHRALGIA (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Joint pain"; RASH (non-serious) with onset 15Oct2021, outcome "recovered" (Oct2021), described as "Rash on right hand (injection in left arm)"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "Feeling brain fog"; ASTHMA (non-serious) with onset 2021, outcome "unknown", described as "Asthma". Therapeutic measures were taken as a result of asthma.  No follow-up attempts are possible. No further information is expected.
The pt's mother noticed on 4th day after vaccination, redness, swelling at area of DTaP vaccination on the left mid thigh. No complaints of pain. She called the office because the red area has increased to 2 1/2 inches, non-tender but feels warm and itches. Not completely sure it is not an insect bite. No fever or any other complaints.
Within 5 days after both vaccines, I started having explosive liquid stools during the night.  Reported to Dr and was dx with Exocrine Panreatic Insuffiency (EPI) and started on Zenpep.
Gave Pfizer Maroon Cap instead of Pfizer Orange Cap and only realized when they scanned the vaccine after the administration.  Dose is invalid and needs to be repeated.  Discussed with family who will return for repeat dose #1
Patient received DTaP #4 on December 16, 2002.  Was seen in the office on December 17, 2002 with a swollen,red and warm left deltoid area.  The patient did not have a fever.  Physician diagnosis was a DTaP reaction.  Treatment recommended was compresses and Tylenol.
Very noticeable tinnitus began 2 days after receiving the vaccination.  Volume is about 4 out of 10, has remained constant ever since.  Ringing with some whooshing, no pulsing, no detrimental effect on perception of music or speech.  Tinnitus became more severe 2 days after receiving a Moderna booster in late November 2021.  I will file a separate VAERS report for the booster shot.
On the 24th I noticed a headache and a sore throat. I made an appointment and had the COVID-19 PCR at the pharmacy and it was positive. I developed a cough and the headache. From there it got worse. I was prescribed Paxlovid by my doctor which he sent to the pharmacy.  I developed A-fib as a result of COVID-19 and had to get on Eliquis. I don't know if it because of COVID-19 or Paxlovid. With the medication, the A-fib stopped. I still have very little energy. I can barely walk a short period of time before getting  winded. I am seeing a pulmonologist for these lingering symptoms.
After receiving FluMist, developed a red/pink rash on his cheeks and nose primarily - not hives, no purulent discharge or itching. Also denied streaks, swelling, and pain. Of note, mom states that after injections, he has always developed a similar rash around the injection site.
Injection site soreness; Ache behind the eyes and like a sinus headache; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; It went down to the neck, shoulder and back and have whole body pain.; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Patient). A 58-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Medical history included he lost his eye sight in service from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration on an unspecified date (at the age of 58-years-old) as dose 1, single for COVID-19 immunisation and experienced injection site soreness. After the 2nd Pfizer covid vaccine patient had injections site soreness and 12 hours after in the middle of the night I started to ache behind the eyes and like a sinus headache then it went down to the neck, shoulder and back and have whole body pain on an unknown date. 10 hours after it began about 24 hours after the injection treatment was received for the events as 400 mg of ibuprofen without thinking about it. to minimize the aches and pains. Now patient worried he blunted the efficacy of the vaccine. Patient took the ibuprofen 24 hours after received the vaccine, 12 hours after had some symptoms. Patient took it 24 hours after the vaccination, 12 hours after the onset of symptoms. The outcome of the events was reported as unknown.  Description of complaint: Caller stated that 12 hours after symptoms he took ibuprofen and he didn't consider how it may blunt or depress the immune response. If it blunted or adversely effected the immune response to the vaccination. He has concerns about the actual level of immunity developed from the second dose and if it may have blunted the effects.  No follow up attempts are needed, No further information is expected.
Had the covid-19 Mma Bivalent vaccine injection on 01/04/2023 and by 01/05/2023 had heart go into afib. Saw a Doctor on 01-09-2023 and set up a time to go to hospital for cardo-inversion on 01/12/2023. By then it had settled down and didn't need the inversion.
Vomiting, screaming, crying, possible seizure, eyes rolled to back of head.
Runny nose; Chills; Headache; Fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and MYALGIA (Body aches) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027LZOA) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced RHINORRHOEA (Runny nose), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Runny nose), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and MYALGIA (Body aches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Pt presented yesterday to with upper abdominal pain past 48 hours. Pain worse with food intake, movement, touch.  Constitutional: Positive for chills and fatigue. Negative for diaphoresis and fever. Gastrointestinal: Positive for abdominal pain and nausea. Negative for blood in stool, constipation, diarrhea and vomiting.   Plan:  -Titrate O2 to maintain Spo2 > 95%  -Albuterol MDI with spacer q4 hr prn   -Airborne, Contact, and Eye protection precautions  -COVID-19 booster due now->outpatient follow-up  Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)
5 minutes after Moderna dose #1 given, patient complained of itchy/irritated throat and lightheadedness.  He was given Benadryl 50 mg at that time.  Showed no improvement over 90 minutes.  Patient was alone.  Accompanied to hospital emergency room.  Had slight shortness of breath.  Observed another 1.5 hours with no worsening of symptoms.  Discharged home with family.
Upon receiving vaccine patient stated that her arm felt immediately warm and itchy.  I examined the area and it was botchy and some what red.  She then said that in the past she had a similar reaction when receiving allergy shots many years ago and would take oral Benadryl.  She was not having any breathing issues and declined epipen.  I offered and she agreed that oral Benadryl would be ok.  I gave her 5ml of generic Benadryl 12/5mg/5ml which is what she stated she usually takes.  After sitting for 10 minutes she stated that her neck was itchy so we repeat the Bendryl dose.  She did state that she was wearing a cloth mask which was new for her.  She thought removing the mask would help which I agreed.    I observed her for an additional 20 minutes.  She stated she was feeling fine, I again checked injection site and redness was gone
Vaccinated with Pfizer in April 2021. Has no symptoms. Had covid in the end of January and bigining of February. Does not feel like sick at all. Discussed plan of care and treatment.   Pt got reinfested with covid.